Bromide

Bromide

SCHEMBL3474229

[Br-].[Br-].[Br-].[Br-].[Mg+2].[Mg+2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL19000 1.00
Water SCHEMBL6696034 0.82
Water SCHEMBL11239599 0.82
Bromide SCHEMBL9421218 0.82
Bromide SCHEMBL21063374 0.82
Bromide SCHEMBL7639809 0.82
Bromide SCHEMBL812148 0.82
Bromide SCHEMBL22158252 0.82
Water SCHEMBL840153 0.82
Bromide SCHEMBL16290293 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020054873-A1 METHOD FOR PRODUCING FIBROIN SOLUTION AND METHOD FOR PRODUCING PROTEIN MOLDED BODY Spiber株式会社 2020-03-19 WO disclosed
EP-2788326-B1 N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE GALDERMA RES & DEV (FR) 2019-04-24 EP disclosed
CN-109071534-A BROMODOMAIN INHIBITORS 艾伯维公司 2018-12-21 CN disclosed
US-9732044-B2 N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use GALDERMA RESEARCH & DEVELOPMENT (FR) 2017-08-15 US disclosed
US-20170066725-A1 N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE GALDERMA RESEARCH & DEVELOPMENT (FR) 2017-03-09 US disclosed
US-9452120-B2 N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-09-27 US disclosed
EP-2788326-A1 N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE Galderma Research & Development (FR) 2014-10-15 EP disclosed
US-20140234245-A1 N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE GALDERMA RESEARCH & DEVELOPMENT (FR) 2014-08-21 US disclosed
US-8703805-B2 Modulators of LXR EXELIXIS PATENT COMPANY LLC (US) 2014-04-22 US disclosed
WO-2013064681-A1 N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-05-10 WO disclosed
CN-100577702-C Propylene block copolymer MITSUBISHI CHEM CORP 2010-01-06 CN disclosed
EP-1910307-A1 PYRAZOLE BASED LXR MODULATORS Exelixis, Inc. (US) 2008-04-16 EP disclosed
WO-2007002559-A1 PYRAZOLE BASED LXR MODULATORS EXELIXIS, INC. (US) 2007-01-04 WO disclosed
CN-1823104-A Propylene block copolymer MITSUBISHI CHEM CORP (JP) 2006-08-23 CN disclosed
EP-0597423-B1 Azetidinone compound and process for preparation thereof TANABE SEIYAKU CO (JP) 2002-03-06 EP disclosed
US-6011150-A SYNTHETIC INTERMEDIATE OF A 1 BETA-METHYLCARBAPENEM DERIVATIVE TANABE SEIYAKU CO., LTD. (JP) 2000-01-04 US disclosed
US-5847115-A Azetidinone compound and process for preparation thereof TANABE SEIYAKU CO., LTD. (JP) 1998-12-08 US disclosed
US-5631363-A ANTIBIOTIC INTERMEDIATE TANABE SEIYAKU CO., LTD. (JP) 1997-05-20 US disclosed
US-5442055-A Chemical intermediates for carbapenicillins TANABE SEIYAKU CO., LTD. (JP) 1995-08-15 US disclosed
EP-0597423-A2 Azetidinone compound and process for preparation thereof TANABE SEIYAKU CO., LTD. (JP) 1994-05-18 EP disclosed